ARTICLE SUMMARY:
Co-founder of Proteus Digital Health, Andrew Thompson has developed both medtech and pharma products. Yet, he offers a less than optimistic perspective on the ability to achieve a similar level of digital disruption in healthcare as has taken place in other industries. The main stumbling block: a healthcare system that remains focused on volume rather than values, and fails to include the most important constituency—patients—as a meaningful player in the overall business model.
Digital health has been among the hottest sectors of life sciences investing over the past decade with investors sinking more than $60 billion into the space. That torrent of funding has produced its share of unicorns, one of those being Proteus Digital Health, a pioneer in digital medicines technology co-founded by Andrew Thompson, who also served as the company’s long-time president and CEO.
